5 ASX shares that I think are your best bet on Melbourne Cup Day

These 5 ASX companies look good value on Melbourne Cup Day

a woman

The Melbourne Cup is a day for punters to aim for the sky and hope for big returns and whilst some punters might disagree, I think you have a better shot investing in the ASX.

Here are five shares that I think are your best bet on Melbourne Cup Day.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is using artificial intelligence (AI) to improve the quality of breast cancer screening and its software as a service (SAAS) model provides plenty of annual recurring revenue. Despite some huge gains (almost 200% since 2016), it has a market cap of only $240 million. Volpara's opportunity is huge and so whilst the road ahead might be filled with lots of volatility, I like its long-term prospects.

Praemium Ltd (ASX: PPS)

The Praemium share price is down 33% since its peak when the recent market turmoil started but the business itself is doing well. The high growth fintech company just recently passed $8.5 billion in funds under administration and tailwinds within the superannuation and pension fund industry could propel it further forward.

Afterpay Touch Group Ltd (ASX: APT)

Afterpay divides opinions but it is taking on big markets and it has a very popular brand. Credit card usage is high enough in Australia, but it's significantly higher in the UK and the US, markets that Afterpay is targeting. If it can get just a small slice of those markets, it could provide huge returns. I don't expect it to be a smooth ride but if it pays off, patient shareholders will be rewarded.

Xero Limited (ASX: XRO)

It's hard to appreciate just how revolutionary Xero's product is if you are not an accountant or if you don't work in a small business. This company makes life easy for its users and it has a very sticky product that is difficult to replace which makes for an attractive investment.

CSL Limited (ASX: CSL)

Despite its recent share price drop, CSL's profit margins are expanding, it's forecasting a 10% – 14% underlying profit growth and it remains one of the ASX's premier biotechnology companies along with Mayne Pharma Group Ltd (ASX: MYX). Perhaps because of its size, it won't have the highest returns on the ASX, but it has a high-quality business and adding those to a portfolio is rarely a mistake in the long run.

If you are looking for more high growth innovative companies, read this report.

Motley Fool contributor Kevin Gandiya owns shares of AFTERPAY T FPO. You can find Kevin on Twitter @KevinGandiya. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia owns shares of AFTERPAY T FPO and Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

An ASX investor relaxes on her couch as the Harvey Norman share price drops due to the shares trading ex-dividend from today.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX managed to pull a rabbit out of the hat today.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Broker Notes

6 ASX stocks receiving analyst downgrades this week

Brokers reduced their ratings on NextDC, Ampol, Regis Resources, and other stocks this week. 

Read more »

Facebook thumbs up symbol surrounded by boxes with the word 'Like'.
Broker Notes

6 ASX stocks upgraded by leading brokers this week

Brokers have raised their ratings on Pro Medicus, South32, New Hope, and others. 

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

6 ASX shares experts are backing amid the market downturn

Brokers maintained a positive view on Qantas, NAB, Maas Group, BHP, and other shares.

Read more »

Two woman holding a tablet and clipboard examine a server rack in a data centre.
ASX Share Market News

Data centre disasters: Why you should think twice before buying Maas Group and NextDC shares

Can these fallen ASX shares bounce back and double from here, or will they keep deteriorating?

Read more »

Two work colleagues looking at a laptop and discussing something.
Broker Notes

Should you buy Hub24, Northern Star, and Transurban shares?

Morgans has given its verdict on these shares. Is it time to buy? Let's find out.

Read more »

Man and woman holding a tablet and clipboard while looking at the backside of server racks in a data centre.
Broker Notes

Buy, hold, sell: Sigma, Cliunvel, and NextDC shares

Let's see how analysts rate these shares this week.

Read more »

AI microprocessor on motherboard computer circuit.
Broker Notes

Xero or hero? UBS predicts the latter with huge upside for the accounting stock

AI is not all doom and gloom for this accounting software provider.

Read more »